2nd Covid Dose – Requests to Receive Earlier due to Travel or Other Reasons

With the increase in cases of the Delta variant, giving people the best possible protection from Covid-19 is vital.

For both adenovirus vector and mRNA vaccines, there is evidence of better immune response and/or protection where longer intervals between doses are used.

Any decision to vaccinate earlier than 8 weeks should be made by the patient’s responsible clinician or vaccination site clinical lead on a case-by-case basis and must be based on clinical risks and benefits of giving the second dose earlier than 8 weeks. For example, transplant patients or those about to undergo immunosuppression treatment